Aelis Farma SA Sustainability Reports
Aelis Farma is a clinical-stage biopharmaceutical company that specializes in the discovery and development of treatments for brain and central nervous system disorders. It focuses on pioneering a new class of drugs that selectively inhibit hyperactivity of the CB1 receptor.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 8945008D5R6WV7EXRN47
FIGI: BBG01522XM14
2 reports from 2023 to 2025
